NO20010166L - Farmasøytiske anvendelser av NAB1 og NAB2 - Google Patents

Farmasøytiske anvendelser av NAB1 og NAB2

Info

Publication number
NO20010166L
NO20010166L NO20010166A NO20010166A NO20010166L NO 20010166 L NO20010166 L NO 20010166L NO 20010166 A NO20010166 A NO 20010166A NO 20010166 A NO20010166 A NO 20010166A NO 20010166 L NO20010166 L NO 20010166L
Authority
NO
Norway
Prior art keywords
nab1
nab2
pharmaceutical applications
pharmaceutical
applications
Prior art date
Application number
NO20010166A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010166D0 (no
Inventor
Martin Braddock
Callum Jeffrey Campbell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en
Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20010166D0 publication Critical patent/NO20010166D0/no
Publication of NO20010166L publication Critical patent/NO20010166L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20010166A 1998-07-11 2001-01-10 Farmasøytiske anvendelser av NAB1 og NAB2 NO20010166L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9814989.1A GB9814989D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method
PCT/GB1999/002199 WO2000003014A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2

Publications (2)

Publication Number Publication Date
NO20010166D0 NO20010166D0 (no) 2001-01-10
NO20010166L true NO20010166L (no) 2001-03-06

Family

ID=26314007

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010166A NO20010166L (no) 1998-07-11 2001-01-10 Farmasøytiske anvendelser av NAB1 og NAB2

Country Status (22)

Country Link
EP (1) EP1097200A1 (id)
JP (1) JP2002520020A (id)
KR (1) KR20010071832A (id)
CN (1) CN1317045A (id)
AP (1) AP2001002038A0 (id)
AU (1) AU763713B2 (id)
BR (1) BR9912018A (id)
CA (1) CA2336805A1 (id)
EA (1) EA200100028A1 (id)
EE (1) EE200100020A (id)
HR (1) HRP20010025A2 (id)
HU (1) HUP0102835A3 (id)
ID (1) ID27742A (id)
IL (1) IL140533A0 (id)
IS (1) IS5788A (id)
NO (1) NO20010166L (id)
NZ (1) NZ509174A (id)
PL (1) PL345507A1 (id)
SK (1) SK382001A3 (id)
TR (1) TR200100622T2 (id)
WO (1) WO2000003014A1 (id)
YU (1) YU1901A (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection

Also Published As

Publication number Publication date
HRP20010025A2 (en) 2001-12-31
NO20010166D0 (no) 2001-01-10
IL140533A0 (en) 2002-02-10
SK382001A3 (en) 2001-09-11
IS5788A (is) 2000-12-22
AP2001002038A0 (en) 2001-03-31
EP1097200A1 (en) 2001-05-09
YU1901A (sh) 2005-06-10
CA2336805A1 (en) 2000-01-20
AU763713B2 (en) 2003-07-31
KR20010071832A (ko) 2001-07-31
HUP0102835A2 (hu) 2001-11-28
EE200100020A (et) 2002-06-17
TR200100622T2 (tr) 2001-10-22
CN1317045A (zh) 2001-10-10
HUP0102835A3 (en) 2003-09-29
PL345507A1 (en) 2001-12-17
BR9912018A (pt) 2006-01-31
NZ509174A (en) 2003-08-29
ID27742A (id) 2001-04-26
EA200100028A1 (ru) 2001-08-27
JP2002520020A (ja) 2002-07-09
WO2000003014A1 (en) 2000-01-20
AU4791499A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
DK0817626T3 (da) Anvendelse af fumagillol og derivater deraf til fremstilling af lægemidler mod tarminfektioner
NO20011496D0 (no) Initiering av eksplosive anordninger
DE69908021T2 (de) Ziprasidonhaltige Arzneimittel
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
NO20004752L (no) Flerlags plastrør og bruk av samme
NO993731L (no) Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne
DE59409323D1 (de) Flächiges Struckturelement und daraus gebildete Packung
NO983678D0 (no) Nye cefemforbindelser og farmasöytiske anvendelser derav
DE69718077T2 (de) Arzneimittel bestehend aus Diclofenac
DE69529848D1 (de) Elektronisches medizinalthermometer
NO20021832L (no) Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
NO20010166D0 (no) Farmasöytiske anvendelser av NAB1 og NAB2
NO20010685L (no) Nye farmasøytiske anvendelser av NOS-inhibitorer
NO963482D0 (no) Medisinsk anvendelse av bromelain
NO20016345D0 (no) Emulsjoner av overflateaktive midler og strukturerte systemer av overflateaktive midler
NO20014454D0 (no) Konstruksjon og anvendelse av samme
NO974966D0 (no) Nye anvendelser av heptafluorpropan
NO20005022L (no) Inhibering av binding av hox og homeodomen-inneholdende proteiner og anvendelser derav
NO20010470D0 (no) Koplingsinnretning og anvendelse av samme
FR2782606B1 (fr) Farine alimentaire et ses applications
KR980000670U (ko) 쌀의 외부배출장치
KR970060188U (ko) 전자제품의 필터 조립 구조
FR2818982B1 (fr) Inhibiteur specifique du systeme ubiquitine-proteasome et applications therapeutiques correspondantes
FI940970A0 (fi) Neutralisering av saopa
UA2674S (uk) Елемент ювелірного виробу

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application